The Metabolic Syndrome and Alzheimer Disease
2007/01/01 by George Razay, Anthea Vreugdenhil, Gordon Wilcock · 27 citations
Medicine · #Dementia and Cognitive Impairment Research #Alzheimer's disease research and treatments #Ginkgo biloba and Cashew Applications
paper · doi:10.1001/archneur.64.1.93
Abstract
BACKGROUND: The metabolic syndrome is a risk factor for cardiovascular diseases, which have been linked to Alzheimer disease. However, a link between Alzheimer disease and the metabolic syndrome has not yet been established. OBJECTIVE: To investigate the relationship between the metabolic syndrome and Alzheimer disease. DESIGN, SETTING, AND PARTICIPANTS: Case-control study of 50 consecutive patients diagnosed with probable Alzheimer disease from the Memory Disorders Clinics, Launceston, Australia, and Bristol, England, and 75 cognitively normal controls. MAIN OUTCOME MEASURES: The odds ratio of the metabolic syndrome as defined by the National Cholesterol Education Program Adult Treatment Panel III. RESULTS: Compared with controls, patients with Alzheimer disease had a significantly larger mean waist circumference, higher mean plasma concentrations of triglycerides and glucose, and a lower mean plasma concentration of high-density lipoprotein cholesterol, but they had lower mean systolic blood pressure. The metabolic syndrome was associated with Alzheimer disease (odds ratio, 3.2; 95% confidence interval, 1.2-8.4; P = .02), and this association was strengthened when the hypertension component was excluded (odds ratio, 7.0; 95% confidence interval, 2.7-18.3; P < .001). All of the analyses were adjusted for age, sex, and location. CONCLUSIONS: This study suggests that Alzheimer disease is associated with the metabolic syndrome. This could have implications for the prevention and treatment of Alzheimer disease.
Cited by
- Estrogen: A master regulator of bioenergetic systems in the brain and body
- Risk Factors for the Progression of Mild Cognitive Impairment to Dementia
- Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. [europepmc]
- PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease. [europepmc]
- The metabolic syndrome and development of cognitive impairment among older women. [europepmc]
- Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. [europepmc]
- The vascular contribution to Alzheimer's disease. [europepmc]
- Habitual sugar intake and cognitive function among middle-aged and older Puerto Ricans without diabetes. [europepmc]
- Obesity, insulin resistance, and Alzheimer's disease. [europepmc]
- Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults. [europepmc]
- Estrogen: a master regulator of bioenergetic systems in the brain and body. [europepmc]
- Risk factors for the progression of mild cognitive impairment to dementia. [europepmc]
- A cross sectional study to examine the association between dietary patterns and cognitive impairment in older Chinese people in Hong Kong. [europepmc]
- Protein post-translational modifications and misfolding: new concepts in heart failure. [europepmc]
- Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer's disease. [europepmc]
- Hypothalamic microinflammation: a common basis of metabolic syndrome and aging. [europepmc]
- Immune aging, dysmetabolism, and inflammation in neurological diseases. [europepmc]
- Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease. [europepmc]
- Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots. [europepmc]
- Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative. [europepmc]
- Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk. [europepmc]
- Recent Research on the Health Benefits of Blueberries and Their Anthocyanins. [europepmc]
- Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study. [europepmc]
- Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer's Disease. [europepmc]
- Associations between metabolic syndrome and type of dementia: analysis based on the National Health Insurance Service database of Gangwon province in South Korea. [europepmc]
- Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. [europepmc]
- Multivariate genomic analysis of 5 million people elucidates the genetic architecture of shared components of the metabolic syndrome. [europepmc]
Related